SCHEMBL20116682

SCHEMBL20116682

CC(C)Nc1cc(-c2noc(C3CCCCC3)n2)ccc1C=N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
CASP3 P42574 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
SENP6 Q9GZR1 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.50
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
KIT P10721 4/20 0.44
PPARA Q07869 1/20 0.43
MMP12 P39900 2/20 0.42
NR1H4 Q96RI1 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20116847 0.91 NPC1 (0.42) NPC1RAB9ACASP3SENP7SENP6
SCHEMBL20116766 0.91 NPC1 (0.42) NPC1RAB9ACASP3SENP7SENP6
SCHEMBL20116798 0.87 KIT (0.42) NPC1RAB9ACASP3SENP7SENP6
SCHEMBL20116883 0.86 NPC1 (0.40) NPC1RAB9ACASP3SENP7SENP6
SCHEMBL20676636 0.85 LMNA (0.46) L3MBTL1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL20676506 0.83 KIT (0.44) KITMMP12
SCHEMBL20676516 0.82 SMN1; SMN2 (0.38) NPC1RAB9ACASP3SENP7SENP6
SCHEMBL20117192 0.82 TLR9 (0.51) CYP3A4CYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL20116690 0.81 GRM5 (0.54) L3MBTL1SMN1; SMN2ALDH1A1MAPK1GAA
SCHEMBL20676451 0.81 CNR1 (0.39) CASP3SENP7SENP6KITNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081167-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS (US) 2018-05-03 WO disclosed